These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25014222)

  • 61. A statistical method to detect chromosomal regions with DNA copy number alterations using SNP-array-based CGH data.
    Lai Y; Zhao H
    Comput Biol Chem; 2005 Feb; 29(1):47-54. PubMed ID: 15680585
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of array-based comparative genomic hybridization with gene expression-based regional expression biases to identify genetic abnormalities in hepatocellular carcinoma.
    Furge KA; Dykema KJ; Ho C; Chen X
    BMC Genomics; 2005 May; 6():67. PubMed ID: 15882461
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma.
    Dalmasso C; Carpentier W; Guettier C; Camilleri-Broët S; Borelli WV; Campos Dos Santos CR; Castaing D; Duclos-Vallée JC; Broët P
    BMC Cancer; 2015 Mar; 15():126. PubMed ID: 25879652
    [TBL] [Abstract][Full Text] [Related]  

  • 64. CNAnova: a new approach for finding recurrent copy number abnormalities in cancer SNP microarray data.
    Ivakhno S; Tavaré S
    Bioinformatics; 2010 Jun; 26(11):1395-402. PubMed ID: 20403815
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
    Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
    Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Allele loss and down-regulation of heparanase gene are associated with the progression and poor prognosis of hepatocellular carcinoma.
    Huang GL; Li BK; Zhang MY; Wei RR; Yuan YF; Shi M; Chen XQ; Huang L; Zhang HZ; Liu W; Huang BJ; Li H; Zheng XF; Luo XR; Wang HY
    PLoS One; 2012; 7(8):e44061. PubMed ID: 22952874
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Association of CHKA polymorphism (rs3794186) with α-fetoprotein levels in hepatocellular carcinoma.
    Park MS; Kim SK; Shin HP; Lee SM; Chung JH
    Mol Med Rep; 2012 Dec; 6(6):1371-4. PubMed ID: 22972156
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Canine Mammary Tumours Are Affected by Frequent Copy Number Aberrations, including Amplification of MYC and Loss of PTEN.
    Borge KS; Nord S; Van Loo P; Lingjærde OC; Gunnes G; Alnæs GI; Solvang HK; Lüders T; Kristensen VN; Børresen-Dale AL; Lingaas F
    PLoS One; 2015; 10(5):e0126371. PubMed ID: 25955013
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Genome-wide analysis of DNA copy number alterations and loss of heterozygosity in intracranial germ cell tumors.
    Terashima K; Yu A; Chow WY; Hsu WC; Chen P; Wong S; Hung YS; Suzuki T; Nishikawa R; Matsutani M; Nakamura H; Ng HK; Allen JC; Aldape KD; Su JM; Adesina AM; Leung HC; Man TK; Lau CC
    Pediatr Blood Cancer; 2014 Apr; 61(4):593-600. PubMed ID: 24249158
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Infrequent amplification of JUN in hepatocellular carcinoma.
    Endo M; Yasui K; Nakajima T; Gen Y; Tsuji K; Dohi O; Zen K; Mitsuyoshi H; Minami M; Itoh Y; Taniwaki M; Tanaka S; Arii S; Okanoue T; Yoshikawa T
    Anticancer Res; 2009 Dec; 29(12):4989-94. PubMed ID: 20044606
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Genomic analysis of liver cancer unveils novel driver genes and distinct prognostic features.
    Li X; Xu W; Kang W; Wong SH; Wang M; Zhou Y; Fang X; Zhang X; Yang H; Wong CH; To KF; Chan SL; Chan MTV; Sung JJY; Wu WKK; Yu J
    Theranostics; 2018; 8(6):1740-1751. PubMed ID: 29556353
    [No Abstract]   [Full Text] [Related]  

  • 73. Identifying associations between genomic alterations in tumors.
    George J; Gorringe KL; Smyth GK; Bowtell DD
    Methods Mol Biol; 2013; 1049():9-19. PubMed ID: 23913205
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Candidate driver genes in focal chromosomal aberrations of stage II colon cancer.
    Brosens RP; Haan JC; Carvalho B; Rustenburg F; Grabsch H; Quirke P; Engel AF; Cuesta MA; Maughan N; Flens M; Meijer GA; Ylstra B
    J Pathol; 2010 Aug; 221(4):411-24. PubMed ID: 20593488
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genome-wide detection of allelic gene expression in hepatocellular carcinoma cells using a human exome SNP chip.
    Park YM; Cheong HS; Lee JK
    Gene; 2014 Nov; 551(2):236-42. PubMed ID: 25192659
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cancer classification using loss of heterozygosity data derived from single-nucleotide polymorphism genotyping arrays.
    Wang Y
    Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():5864-7. PubMed ID: 17945917
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast.
    Hawthorn L; Luce J; Stein L; Rothschild J
    BMC Cancer; 2010 Aug; 10():460. PubMed ID: 20799942
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
    Wang K; Lim HY; Shi S; Lee J; Deng S; Xie T; Zhu Z; Wang Y; Pocalyko D; Yang WJ; Rejto PA; Mao M; Park CK; Xu J
    Hepatology; 2013 Aug; 58(2):706-17. PubMed ID: 23505090
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Subtypes of familial breast tumours revealed by expression and copy number profiling.
    Waddell N; Arnold J; Cocciardi S; da Silva L; Marsh A; Riley J; Johnstone CN; Orloff M; Assie G; Eng C; Reid L; Keith P; Yan M; Fox S; Devilee P; Godwin AK; Hogervorst FB; Couch F; ; Grimmond S; Flanagan JM; Khanna K; Simpson PT; Lakhani SR; Chenevix-Trench G
    Breast Cancer Res Treat; 2010 Oct; 123(3):661-77. PubMed ID: 19960244
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.
    Huh J; Tiu RV; Gondek LP; O'Keefe CL; Jasek M; Makishima H; Jankowska AM; Jiang Y; Verma A; Theil KS; McDevitt MA; Maciejewski JP
    Genes Chromosomes Cancer; 2010 Apr; 49(4):390-9. PubMed ID: 20095039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.